IMA - Distributed Manufacturing trials

the other option as mentioned above is each space go out and ask 5 clinics/hospitals/care facilities what is the 5 thing at the top of their wish /needs list. Some might be outlandish or fall outside our capacities to produce for various reasons. But it will be better than just brainstorming on assumptions?
we overlay our the need with capacity to execute with legal etc constraints, that will narrow the field to something worth doing and do-able.

3 Likes

Yes absolutely @Felix - what you are suggesting here, drawing on what we talked about earlier in thread, is exactly in alignment with our thinking for discussion during the check-in meeting tomorrow.

I think that having that conversation with healthcare facilities regarding wish lists, with those criteria in mind can help to keep the conversation on a practical level - as you state, to overlay our the need with capacity to execute with legal etc constraints, that will narrow the field to something worth doing and do-able.

1 Like

Update on the timeline for the first distributed manufacturing trial

900 writing aids will be produced in the 9 makerspaces participating to the IMA project, in Ghana, Kenya and South Africa.

Product and specification documents is available here: RFQ trial1 - IMA - Google Slides

  • Workshop on “Pricing for production” 15th August - Register here: Meeting Registration - Zoom

  • Deadline for bids submission: 20th August.

  • Communication of selected bids: 30th and 31st August.

  • Production window: 1st to 30th September 2023.

Quotations must be sent to contracts@distributedmanufacturing.org before 20th August 2023. The Request for Quotations is only for individual makers (or their organisations) associated with the following 9 participating makerspaces: D&T Institute (Accra); Kumasi Hive (Kumasi); Triple Dimension (Kumasi), FabLab Winam (Kisumu); Gearbox (Nairobi); IOMe 254 (Lamu), Maker Station (Cape Town); Makerspace (Durban); TMG Makerspace (Johannesburg).

Writing Aid by MakersHelpCare is licensed under the Creative Commons - Attribution license.

2 Likes

Thanks for the update!

1 Like